摘要
目的对酶联免疫法检测HBsAg和荧光定量PCR检测HBV-DNA结果行对比研究,探讨其临床意义。方法对45例HBsAg阴性的慢性乙型肝炎HBV感染患者采用ELISA检测HBVM(HBsAg、抗-HBs、HBeAg、抗-HBe、抗-HBc),同时采用PCR对其血清HBV-DNA进行定量分析;对照组为同期慢性乙型肝炎患者。结果45例HBsAg阴性慢性乙型肝炎患者中,HBV-DNA阳性率为24.44%。结论ELISA法检测HBV是不全面的,但PCR只能检出复制状态的病毒,难以表达非复制状态的感染,因而用PCR方法检测HBV-DNA也不能完全代替血清标志物的检测。建议必要时两者结合加强对患者的检测,以避免临床不必要的漏检。
Objective To compare the clinical value and reliability of ELISA (enzyme linked immunosorbent assay) and PCR(polymerase chain reaction)in examining HBsAg(hepatitis B surface antigen)and HBV-DNA(hepatitis B virus-DNA). Methods Examining HBVM (HBsAg,Anti-HBs, HBeAg,Anti-HBe,Anti-HBc)by ELISA and HBV-DNA by PCR of 45 HBV patients. Results Of all the 45 HBV patients, the positive rate of HBV-DNA was 24.44%. Conclusion ELISA and PCR can not correctly examine the results and in clinical we should examine blood by both.
出处
《中国现代医生》
2009年第13期26-27,共2页
China Modern Doctor